Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. - Wikidata - awgldk - TriplyDB

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

http://www.wikidata.org/entity/Q36059237

about

Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden Cardiac toxicity of trastuzumab in elderly patients with breast cancer Adjuvant systemic therapy in older women with breast cancer Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies Screening mammography in older women: a review Prognostic factors in elderly patients with breast cancer Optimal management of breast cancer in the elderly patient: current perspectives Adjuvant treatment for older women with invasive breast cancer Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis Breast cancer and aging: results of the U13 conference breast cancer panel Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer.Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Age-specific changes in intrinsic breast cancer subtypes: a focus on older women Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.Cancer survivorship and aging : moving the science forward.Adjuvant chemotherapy in older women with early-stage breast cancer.Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis.Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer.Adjuvant therapy for women over age 65 with breast cancer The treatment of early breast cancer in women over the age of 70 Breast cancer methylomes establish an epigenomic foundation for metastasis.Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer.Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries.Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.Gene-expression signature functional annotation of breast cancer tumours in function of age Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis.Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis.Predictors and outcomes of completion axillary node dissection among older breast cancer patients Pharmacokinetics of chemotherapy in the older patient.Tolerance to chemotherapy in elderly patients with cancer.

P2860

Q25257242-E885C17C-9ECE-437A-A77E-CFCE904293B8 Q26741182-CB076CA7-1D4F-4D67-8400-ABEA33327A0B Q26741523-3D7DA2BD-8240-47FE-9B66-7EE6C8DA18E1 Q26749492-526DA8E3-E58B-44CB-B7A5-BDDA37403B19 Q26829839-94442B0E-F243-4839-84E1-01793566FDBC Q26852883-C3380B09-BD48-43FE-97E5-840FB69EE6C5 Q27690879-B6420D9A-A9EE-49A3-B665-8080F036F588 Q28066744-A0D67B45-B587-4E86-9B11-9CB0D7C152A3 Q30845285-56A1A7F8-25D1-4335-B730-7F6C62A2E1CF Q33385774-60BB9272-BC68-4244-9F0D-D5C7FC43C3C5 Q33398947-2D80FC53-87A6-4753-8ED8-15C313C39885 Q33572119-1F32DB29-FBD7-4D34-AB93-86BEA4E1EC0E Q33789362-F2208993-F0FA-421B-989F-070F06986DB2 Q33829433-4C87EA05-B17A-4E57-9634-D1A3B14F0B7D Q33990818-1D1C6513-391B-4259-B0B8-51117C9A7A61 Q34071621-CFAE2F63-82E4-4881-999C-EF3A0225FBA5 Q34096177-1A83B4CC-1C5D-47F9-9A2C-6418118996AE Q34359310-E661DC09-2544-4A58-99FB-4DA3F0B52067 Q34682115-34BEC337-0CC0-405B-8A1A-4D12C560CA40 Q34700696-FFC4C141-BF4D-4B38-A4D4-AAB38FEF9510 Q34858284-56381E54-694D-40B2-A3CF-E4B0E8795C95 Q34871753-0F933180-3D88-4985-AACB-784016227760 Q34879258-321F79C6-27E8-478A-A1D0-27FF3EC32C02 Q34959972-E0D84A49-441D-4E03-9AE6-A6B91B79D089 Q35051020-CB1182AF-3A4B-44DF-A0C8-AD4E1D194EFA Q35051256-58B7657B-8C3B-423F-94C0-2B236F19AC34 Q35125666-F060A7FB-D250-4003-92C4-8D64D32356E0 Q35136051-ADA3DB84-CB1A-4D84-81DB-7CE6567C59AE Q35583728-C153D273-40B2-44AA-A32F-222AC28AA6A6 Q35644643-C1A851B5-EFFF-4C50-8B8F-270C345C6122 Q35771257-23108171-1736-411C-AF76-B6DC996A233D Q35849104-B6AAA6D4-C959-4D53-B01C-429FEDB694B1 Q35902810-FF94A5E8-2615-4100-B6C8-8CD2FA17C9B6 Q36089048-94E11CCD-61F6-465D-9F34-3A08D98C38DB Q36416237-E481A5B9-1D8D-4BC6-BCC8-F3BF09A46A73 Q36565659-05F184B1-9B4E-46EC-91BF-4275EFDA6EBE Q36610747-13FF67BF-7E5B-47F2-9E0F-FC943D60ADC8 Q36692444-DACD73AC-0AD9-42BC-A99B-073430645BEC Q36715263-7F2EE509-0321-4735-AB69-45CF2E78DE8E Q36715266-80D1DFD7-8352-44CE-BC86-0AD105EA7DDF

P2860

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

http://www.wikidata.org/entity/Q36059237

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@ast

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@en

type

label

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@ast

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@en

prefLabel

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@ast

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@en

P1433

Q36059237-A2BB0BF4-1E40-42CB-9D29-442B305C9316

P1476

Q36059237-BB01A64E-7C00-4D33-9489-592EECDAF28F

P2093

Q36059237-175ED205-CA9D-4183-BFA3-26C4A64D3B76

Q36059237-24CF4D41-15FA-4BB5-B892-C94D4919FE9D

Q36059237-258A448C-F263-494E-BEC9-865199B727E9

Q36059237-2B1E03F3-A276-4CB1-99DF-BC0C5B376276

Q36059237-4D3EEF9C-CA22-4327-A9A6-3A76A4624FFE

Q36059237-539ABD69-71D6-4A2F-BCB8-B3BCCD00DC46

Q36059237-5F063880-799D-4171-A7B0-DA9E636CD55B

Q36059237-5FE826D3-96DA-4E0C-B1B5-79519EEA3A75

Q36059237-6E5ECAB7-8A99-46C3-B7AD-CD238178A9AE

Q36059237-A27D412E-C1A3-4478-A056-2DDEAE713476

P304

Q36059237-ACE4A8A5-23B3-4941-A58E-E7B9C91D3884

P31

Q36059237-DD4FD5E0-B8A0-400D-9994-B45C2465AFC9

P356

Q36059237-D6A82716-9753-40AC-898E-2FCE4E2F2F77

P407

Q36059237-6C160ED4-BAAE-47E6-A973-B9AE2CDAEDC9

P433

Q36059237-80271062-DDC4-4F4D-AF6C-C15D2F0211AE

P478

Q36059237-DFEB701B-B742-49F5-BE98-E013DC3AF17D

P50

Q36059237-1965FC72-37D1-4075-A39B-5002053A8174

Q36059237-3DE4D58D-65A4-4369-B489-6DBF44BE7831

P577

Q36059237-48BE3807-979A-49DF-934F-71E26DCF2BE8

P5875

Q36059237-8494A339-FA30-4CFE-8FC4-08CE10C5A30E

P698

Q36059237-90D7E725-0513-4EA1-A540-8F1D1F82A74E

P921

Q36059237-6B6593D8-EBE0-427E-A8AA-E3BD158E2FDA

Q36059237-B1E9173B-F95A-4C86-AA7D-444A5EC99A0D

P356

JAMA.293.9.1073

P1433

Journal of the American Medical Association

P1476

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

@en

P2093

Clifford Hudis

http://www.w3.org/2001/XMLSchema#string

Constance Cirrincione

http://www.w3.org/2001/XMLSchema#string

Daniel Budman

http://www.w3.org/2001/XMLSchema#string

Donald Berry

http://www.w3.org/2001/XMLSchema#string

Eric Winer

http://www.w3.org/2001/XMLSchema#string

Harvey Cohen

http://www.w3.org/2001/XMLSchema#string

Hyman B Muss

http://www.w3.org/2001/XMLSchema#string

I Craig Henderson

http://www.w3.org/2001/XMLSchema#string

Judith Wheeler

http://www.w3.org/2001/XMLSchema#string

Raymond B Weiss

http://www.w3.org/2001/XMLSchema#string

P304

1073-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.293.9.1073

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Cancer and Leukemia Group B

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7991548

http://www.w3.org/2001/XMLSchema#string

P698

15741529

http://www.w3.org/2001/XMLSchema#string

P921